Skip to main content
Premium Trial:

Request an Annual Quote

Keeping It Level, For Now

Funding levels in the US are staying at fiscal year 2010 levels for a little longer as Congress approved a continuing resolution while they hammer out the 2011 budget, reports Writedit at Medical Writing, Editing & Grantsmanship. She also points to a press release from the Association of American Medical Colleges that notes that the resolution lasts through the 18th of December. AAMC adds that Rep. Jerry Lewis (R-Calif.), who is on the appropriations committee, "again expressed opposition to 'any potential omnibus spending bill.' ... He also opposed extending the CR for the balance of FY 2011 at current level, which he described as 'frankly, too darn high.'"

At his blog, DrugMonkey looks into how continuing resolutions affect the funding of grants by searching through Reporter. He is surprised to find that seven NIH institutes "are on the ball with multiple new awards each" with December start dates.

The Scan

Could Cost Billions

NBC News reports that the new Alzheimer's disease drug from Biogen could cost Medicare in the US billions of dollars.

Not Quite Sent

The Biden Administration likely won't meet its goal of sending 80 million SARS-CoV-2 vaccine doses abroad by the end of the month, according to the Washington Post.

DTC Regulation Proposals

A new report calls on UK policymakers to review direct-to-consumer genetic testing regulations, the Independent reports.

PNAS Papers on Mosquito MicroRNAs, Acute Kidney Injury, Trichothiodystrophy

In PNAS this week: microRNAs involved in Aedes aegypti reproduction, proximal tubule cell response to kidney injury, and more.